Guest guest Posted March 7, 2006 Report Share Posted March 7, 2006 What Dow Knew.. & ..When Dow Knew It Fact Long Suppressed About The Dangers of Silicone! _____ Click on (numbers) for Source. _____ Dow Corning's full culpability in the silicone breast implant controversy is not widely known. For decades the company chose to keep secret a series of warning signals about silicone, and made misleading and false statements to the women who received implants. The original Dow Corning sales pitch, in a brochure entitled " Facts About Your New Look, " promised a lifetime of safety and satisfaction. Silicone breast implants were advertised as benign and chemically inactive. In fact, Dow Corning had no substantial evidence of safety, but had plenty of evidence that silicone implants were a high-risk product. The beginning of the story goes back 60 years!!! 1950's-- Silicone injections are banned in Japan because of dangerous side effects, including immunological problems. 1954--A Dow Coming Chemical study finds that a chemical in silicone, called silica, has " quite a high order of toxicity, " but this study is not released publicly. <http://www.siliconeholocaust.org/whatdowknew.html#1 (1) 1956-- Again a Dow Corning Chemical study calls into question the safety of silicone, and again it is concealed from the public. Silicone fluid fed to laboratory dogs is found to migrate throughout their bodies and lodge in vital organs. <http://www.siliconeholocaust.org/Source2.html (2) 1960's-- California and Nevada pass laws against silicone injections, classifying them a criminal offence. 1961 -- As Dow Corning prepares to market the first silicone breast implants the company is advised by its own Center for Aid to Medical Research that silicone will bleed through a silicone bag and be absorbed into human tissue. <http://www.siliconeholocaust.org/Source3.html (3) Silicone leaking from implants can be equivalent to injections of silicone into the body. 1962-- Alarmed about the health dangers posed by silicone, the FDA issues strict new regulations governing silicone injections. 1963-- Dow Corning begins selling silicone breast implants under the trade name " Silastic " without long-term testing or monitoring of the women who receive them. No mention whatsoever is made of possible health risks, and because the silicone is contained inside a " protective " bag the breast implants are not within the purview of the FDA regulations. 1964-- In a letter to the FDA, Dow Corning lawyers represent that liquid silicone, a major component of the silicone-gel implant, is not absorbed by the body. However internal Dow Corning testing had already conclusively demonstrated the exact opposite. <http://www.siliconeholocaust.org/Source4.html (4) 1965-- A study finds that lumps develop under the skin when silicone enters human tissue, but Dow Corning continues to insist that silicone is an inert substance. <http://www.siliconeholocaust.org/Source5.html (5) 1967-- Dow Corning and three of its top executives are criminally indicted by a federal grand jury in Bay City, Michigan, for permitting deliveries of silicone without FDA approval. 1968-- When silicone bags are implanted into dogs the silicone leaks out and is dispersed throughout their systems, according to another secret study for Dow Corning. <http://www.siliconeholocaust.org/Source6.html (6) 1970-- Dow Corning reports to the scientific community that implants caused no adverse health consequences in four laboratory dogs. Later, because of the discovery process in court, it will be revealed that one of the dogs died and the other three suffered chronic inflammation. <http://www.siliconeholocaust.org/Source7.html (7) <http://www.siliconeholocaust.org/whatdowknew.html#7 1972-- Dow Corning pharmacologist, Don , notes in an internal memo that economic considerations are constraining research into the biological applications of silicone. Dr. later quits in a falling-out with the company over the lack of research. <http://www.siliconeholocaust.org/Source8.html (8) 1975-- Numerous plastic surgeons complain to Dow Coming that its newly redesigned silicone implants appear oily and seem to be leaking even before they are surgically inserted. http://www.siliconeholocaust.org/Source9.html (9) Some surgeons report that the implants appear to have been soaked in Mazola oil. <http://www.siliconeholocaust.org/Source10.html (10) One Dow Corning executive instructs company salesmen to wash and towel-dry the implants before displaying them to surgeons, thus concealing the leakage problem. <http://www.siliconeholocaust.org/Source11.html (11) 1975-- Dow Corning employees are compelled to edit a training video for plastic surgeons when implants rupture during the filming of the video. <http://www.siliconeholocaust.org/Source12.html (12) 1976-- Talcott, a senior Dow Corning materials engineer, quits in a dispute over the safety of silicone implants. He will later tell a news reporter, " The manufacturers and surgeons have been performing experimental surgery on humans. " <http://www.siliconeholocaust.org/Source13.html (13) 1976-- A Dow Coming internal study reveals that the lining of silicone implants loses strength even when sitting on a shelf. <http://www.siliconeholocaust.org/Source14.html (14) 1976-- A Dow Corning technical-services specialist, Art Rathjen, complains in a letter to his superiors about the lack of any scientific evidence proving the safety of silicone breasts: " I have proposed again and again that we must begin in-depth study of our gel, envelope, and bleed phenomenon. <http://www.siliconeholocaust.org/Source15.html (15) 1977-- A Dow Corning marketing executive, Chuck Leach, tells a gathering of the International Society of Plastic Surgeons that Dow Coming has a study underway on the possible seepage of silicone from breast implants. Mr. Leach says later he had his fingers " crossed " at the time. <http://www.siliconeholocaust.org/Source16.html (16) In fact, no such study existed. 1978-- Dow Coming represents in a patient brochure that " laboratory studies " prove that implants should " last a lifetime. " At the same time, Dow Corning is receiving numerous complaints of spontaneous rupture from surgeons and sales representatives. Another senior Dow Corning engineer writes to his superiors about implants: " When will we learn at Dow Corning that making a product 'just good enough' almost always leads to products that are 'not quite good enough'? " <http://www.siliconeholocaust.org/Source17.html (17) 1980-- The chief of biomaterial safety for Dow Coming, Boley, tells a private physician it is highly improbable a woman's onset of lupus is connected to her silicone breasts. Mr. Boley claims the implants have been proven safe in " extensive " testing, although three years later he will admit the opposite, saying there is " no valid long-term implant data to substantiate the[irl safety,. " <http://www.siliconeholocaust.org/Source18.html (18) 1984-- The first woman with autoimmune disorder recovers damages. Stern was awarded $1.5 million in punitive damages. Dow Corning was found fraudulent, having misrepresented animal studies. 1985-- In an internal report by Boley and other Dow Corning scientists, the company concludes that the preponderance of available data suggests that silicone can produce immune-mediated diseases. <http://www.siliconeholocaust.org/Source19.html (19) At the same time Dow Coming continues to state publicly there is no evidence that silicone causes disease. 1988-- Thousands of women are believed to be experiencing complications with silicone implants, according to the Public Citizen Health Research Group. The complaints include rocklike deformities and chronic inflammation of the breasts, plus more serious diseases such as lupus, systemic sclerosis and neurologic dysfunction. The Food and Drug Administration rules that breast implants should be classified high risk and mandates that manufacturers produce safety data. 1991 -- A San Francisco jury finds against Dow Corning in a lawsuit charging the company with fraud, negligence and product liability for not disclosing information about the dangers of breast implants. The plaintiff in the suit is nn Hopkins, a woman with implants who developed a painful, arthritic-like condition. 1992-- The FDA limits the future sales of silicone implants after the " safety " data produced by the manufacturers is ruled patently inadequate--there are no clinical studies. Under the new rules, implants can be sold only as part of supervised clinical studies. FDA Commissioner Kessler cites a 70-percent rupture rate as one of the problems with implants. 1993-- For the first time Dow Coming acknowledges that silicone may not be inert, revealing that complaining researchers found a possible link between silicone and immune-system disease in a study on laboratory rats. The chief medical officer for Dow Corning, Dr. Myron on, is quoted as saying, " It clearly raises my concern that silicone gel might cause immune-system disease. " <http://www.siliconeholocaust.org/Source20.html (20 & 21) 1994-- Lawsuits are filed against Dow Coming by plastic surgeons who claim the company damaged their medical reputations by misrepresenting the quality of implants. 1995-- A judge rules that Dow Corning's parent company, Dow Chemical, can be held liable in lawsuits involving silicone implants. Dow Coming files for bankruptcy protection. <http://www.siliconeholocaust.org/ HOME _____ (1) Request for Applications Testing on Dow Coming Silica, " Sept. 1, 1954 (TDCH- 1-55) (2) " The Physiological Assimilation of Dow Coming 200 Fluid. " by Chenoweth, 1956. (3) Letter from Ethel Mullison, staff associate, Dow Coming Center for Aid to Medical Research, to Dr. Cronin, Jan. 24, 1961. (4) Letter from Harry Dingman to Food and Drug Administration. Nov.7, 1964 (M35009-012) 'The Physiological Assimilation of Dow Coming 200 Fluid, " 1956. (5) " Siliconoma: Another Cutaneous Response to Dimethylpolysiloxane, " by Ben-Hur, 1965. (6) Letter from E. Hobbs, toxicologist, to Dr. Raffkin, Squibb Institute for Medical Research, Oct. 6, 1968. (7) Two-year study with Silastic Memory Implants TX-202A and TX202B in Dogs. " April 20, 1970 (F462-483) (8) Deposition of Don (DCC 16001173-16001178). (9) Memo to Dow Coming mammary task force from Talcott, senior engineer, May 15, 1975. (10) Deposition of Dumas (KKA 119771-119774) (11) Memo to Dow Coming sales staff and other company officials from Tom Salisbury, May 16, 1975. (12) Deposition (M190200-190202) (13) " Breast Implants: What did the Industry Know, and When? " Business Week, June 1, 1991 (14) Deposition (T 21431-2144) (15) Memo to A.E. Bey and C.W. Lentz, Dow Corning managers, from Art H. Rathjen, June 8, 1976 (16) Memo to Bob Levier, Dow Corning implant products PXG, from Leach, March 31, 1977 (17) Memo from Farnk to Milt Hinsch, March 2, 1978 (18) Letter from F. Boley, senior group leader, Health Core Group Reseach, Down Corning, to ph R. Connelly, M.D., Buffalo, N.Y., April 23, 1980, and memo to J. and C. Jakubczak, Dow Corning managers,Sept. 15, 1983 (19) Report by Boley et al, Feb. 19, 1985 (KMM386 643-695) (20) " Dow Corning Reveals: Study Shows Possible Immune System Link, " Midland Daily News, March 19,1993, p.1. (21) " Informed Consent, " by A. Byrne, McGraw-Hill, 1996 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.